Elevance's CFO cut roughly a third of his reported common stock in one day, selling 10,584 shares for about $4.65 million into prices as high as $447.19. No 10b5-1 plan is flagged, which makes this a discretionary exit by the person who knows the Medicare Advantage cost math best.
Latest Activity
The managed-care insurer heads into today's earnings report already on the back foot, down 4.38% on the day. That slide sets a low bar for how the report lands.
Elevance reports before the open at 6:00 AM ET with four straight EPS beats behind it, the last one topping estimates by 20.6%. Consensus sits at $4.69 on $49.16 billion in revenue, and Medicare Advantage cost trends are the line that decides how insurers trade today.
Elevance Health just set a new 52-week high at $425.27, a full round trip from its March low.
ELV Coverage
UnitedHealth is Down Big Over 3 Months: A Big Bank Says 40% Gains to Come After Raising Their Target
UnitedHealth has shed members, slipped 10% in three months, and closed lower on a beat-and-raise quarter. Now a major Wall Street firm is calling for 40% gains, and its argument centers on…
UnitedHealth Rises 4% on Earnings Beat and Raised Full-Year Outlook; Humana Advances 2%
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) shares are up 4% to $395.19 after the health insurer topped Q3 2026 profit estimates and raised its full-year outlook. The beat came on the…
UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not
UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding…
UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation
TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped…
Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a…
Billionaire Investor Seth Klarman’s Top 5 Stocks: Would He Buy More Today?
Seth Klarman's Baupost Group just revealed its five largest stock positions, and the list includes a little-known industrial distributor posting explosive earnings growth alongside household names bleeding on the front page. Reverse-engineering…
Equal-Weight Strategy RSP Could Outrun SPY if This Macro Shift Continues
RSP is beating SPY for the first time in years, but two specific signals will determine whether equal-weight strategies keep their edge or surrender it back to the mega-caps before year end.
Big Hospital Systems Are Dropping Medicare Advantage Plans Mid-Contract. Patients Find Out by Letter
Your Medicare Advantage plan stays active on paper, but the hospital you have used for decades can quietly vanish from your network before your next appointment, and the protections meant to help…
The Main Reason Behind Buying UnitedHealth Before July 16
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of…
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial intelligence (AI) is designed to compress each…
Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital
Income investors shopping the healthcare aisle often land on Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), a closed-end fund managed by Gabelli Funds that has quietly paid quarterly distributions for more than 14…
Elevance Health Reinstated at Inline by Evercore ISI: Is the Medicare Advantage Bounce Already Priced In?
Elevance Health (NYSE:ELV | ELV Price Prediction) stock surged this week after the Centers for Medicare & Medicaid Services finalized a 2.48% Medicare Advantage payment rate increase for 2027, coming in above…
UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) stock is up nearly 11% today, moving from $281.36 to $311 and change, as the managed care sector stages a powerful relief rally. Humana (NYSE:HUM)…
5 Stocks That Should Benefit from the 2026 Medicare Advantage Rate Decision
The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly…
UnitedHealth Price Target Raised to $337 by BofA After Medicare Advantage Rate Finalization
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) stock got a meaningful vote of confidence from Bank of America on Tuesday, as analyst Kevin Fischbeck raised the firm’s price target to $337 from…